Betalin Therapeutics
Dr. A. M. James Shapiro (born in Leeds, England) is a British-Canadian surgeon best known for leading the clinical team that developed the Edmonton Protocol – an islet transplant procedure for the treatment of type 1 diabetes. Dr. Shapiro is Professor of Surgery, Medicine, and Surgical Oncology at the University of Alberta[1] and the Director of the Clinical Islet Transplant Program and the Living Donor Liver Transplant Program with Alberta Health Services.
This person is not in the org chart
This person is not in any offices
Betalin Therapeutics
Betalin Therapeutics develops a cell therapy solution for insulin-dependent diabetes, an Engineered Micro-Pancreas (EMP).